| Effect | None |
| Trial Design | Double blind |
| Trial Length | 6+ Months |
| Number of Subjects | 78 |
| Sex | Both Genders |
| Age Range | 65+ |
The scores on the rating scales associated with cognitive decline and dementia (Hasegawa and MMSE) were improved with phosphatidylserine supplementation in elderly persons over 6 months at 300mg; performance in rating scales associated with everyday cognition were not significantly affected.
